Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/23939
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWiendl, Heinz-
dc.contributor.authorGross, Catharina C.-
dc.contributor.authorEschborn, Melanie-
dc.contributor.authorWeisser, Linda-
dc.contributor.authorPosevitz-Fejfar, Anita-
dc.contributor.authorSchulte-Mecklenbeck, Andreas-
dc.contributor.authorVAN WIJMEERSCH, Bart-
dc.contributor.authorHupperts, Raymond-
dc.contributor.authorBrette, Sandrine-
dc.contributor.authorTurner, Timothy J.-
dc.contributor.authorBar-Or, Amit-
dc.contributor.authorKlotz, Luisa-
dc.date.accessioned2017-06-30T10:24:43Z-
dc.date.available2017-06-30T10:24:43Z-
dc.date.issued2017-
dc.identifier.citationMULTIPLE SCLEROSIS JOURNAL, 23(1), p. 144-144 (Art N° 69)-
dc.identifier.issn1352-4585-
dc.identifier.urihttp://hdl.handle.net/1942/23939-
dc.description.abstractTeriflunomide, an immunomodulator approved for patients with relapsing forms of MS, specifically inhibits proliferation of activated lymphocytes. Teri-DYNAMIC (NCT01863888) characterized the immunomodulatory effects of teriflunomide treatment on lymphocyte subsets in patients with relapsing–remitting multiple sclerosis (RRMS). Objectives: To explore the immunomodulatory effects of teriflunomide on lymphocyte subsets, receptor repertoire, and function in patients with RRMS.-
dc.description.sponsorshipFunding was provided by Sanofi Genzyme. This work was previously presented at AAN 2016.-
dc.language.isoen-
dc.publisherSAGE PUBLICATIONS LTD-
dc.titleTeri-DYNAMIC: Exploring the impact of teriflunomide on immune cell population size, receptor repertoire, and function in patients with RRMS-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateNOV 17-19, 2016-
local.bibliographicCitation.conferencename9th Latin American Congress of Multiple Sclerosis (LACTRIMS)-
local.bibliographicCitation.conferenceplaceBuenos Aires, ARGENTINA-
dc.identifier.epage144-
dc.identifier.issue1-
dc.identifier.spage144-
dc.identifier.volume23-
local.format.pages1-
local.bibliographicCitation.jcatM-
dc.description.notes[Wiendl, H.; Gross, C. C.; Eschborn, M.; Weisser, L.; Fejfar, A. Posevitz; Mecklenbeck, A. Schulte; Klotz, L.] Univ Munster, Munster, Germany. [Van Wijmeersch, B.] Hasselt Univ, Hasselt, Belgium. [Hupperts, R.] Maastricht Univ, Med Ctr, Orbis Med Ctr, Maastricht, Netherlands. [Brette, S.] Lincoln, Boulogne, France. [Turner, T. J.] Sanofi Genzyme, Cambridge, MA USA. [Bar-Or, A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.-
local.publisher.placeLONDON-
local.type.refereedNon-Refereed-
local.type.specifiedMeeting Abstract-
local.bibliographicCitation.artnr69-
dc.identifier.doi10.1177/1352458516666193-
dc.identifier.isi000393906000059-
item.fulltextWith Fulltext-
item.contributorWiendl, Heinz-
item.contributorGross, Catharina C.-
item.contributorEschborn, Melanie-
item.contributorWeisser, Linda-
item.contributorPosevitz-Fejfar, Anita-
item.contributorSchulte-Mecklenbeck, Andreas-
item.contributorVAN WIJMEERSCH, Bart-
item.contributorHupperts, Raymond-
item.contributorBrette, Sandrine-
item.contributorTurner, Timothy J.-
item.contributorBar-Or, Amit-
item.contributorKlotz, Luisa-
item.fullcitationWiendl, Heinz; Gross, Catharina C.; Eschborn, Melanie; Weisser, Linda; Posevitz-Fejfar, Anita; Schulte-Mecklenbeck, Andreas; VAN WIJMEERSCH, Bart; Hupperts, Raymond; Brette, Sandrine; Turner, Timothy J.; Bar-Or, Amit & Klotz, Luisa (2017) Teri-DYNAMIC: Exploring the impact of teriflunomide on immune cell population size, receptor repertoire, and function in patients with RRMS. In: MULTIPLE SCLEROSIS JOURNAL, 23(1), p. 144-144 (Art N° 69).-
item.accessRightsRestricted Access-
crisitem.journal.issn1352-4585-
crisitem.journal.eissn1477-0970-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
10.1177@1352458516666193.pdf
  Restricted Access		Published version640.14 kBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.